Case File
efta-02582668DOJ Data Set 11OtherEFTA02582668
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02582668
Pages
5
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Tazia Smith
Sent:
Monday, April 7, 2014 4:53 PM
To:
[email protected]
Subject:
Re: *** NEW JOINT BOOKRUN IPO *** SABRE CORPORATION (NASDAQ: SABR) *** [CJ
Classification: Confidential
understood
Tazia Smith
Director I Key Client Partners - US
DB Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 10154-0004 New York, NY, USA Tel.
Email
From: Jeffrey Epstein <jeevacation@gmai=.com>
To:
Tazia Smith/db/dbcom@DBAMERICAS,
04/07/2014 12:50 PM
Subject:
Re:'** NEW JOINT BOOKRUN IPO *** SA=RE CORPORATION (NASDAQ: SABR) *** IC)
sabre only
On Mon, Apr 7, 2014 at 12:47 PM, Tazia Smith
target=_blank>
wrote:
Classification: Confidential
Thanks for coming back Jeffrey. Passive deals too, or just the Sabre?=/font>
EFTA_R1_01760461
EFTA02582668
Tazia Smith
Director Key Client Partners - US
DB Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 10154-0004 New York, NY, USA Tel.
From: Jeffrey Epstein <[email protected] <mailto:[email protected]»
To:
Tazia
04/07/2014 12:29 PM
Subject:
Re: • ** NEW JOINT BOOKRUN IPO '•• SA=RE CORPORATION (NASDAQ: SABR) "••
max buy
On Mon, Apr 7, 2014 at 12:24 PM, Tazia Smith <
wrote:
Jeffrey - <=r>
In addition to this IPO of Sabre Corp (SABR) next week (below), DB is passi=e on La Quinta Holdings (LQ), Ally Financial
(ALLY), and Enable Midstream (ENBL) this week. Call us at your convenience to discuss -- these specifically, and
simplifying the process of indicating and selling in general.
Best Regards,
Tazia
"• APPROVED FOR EXTERNAL DISTRIBUTION •"•
Issuer: Sabre Corporation
Symbol: SABR
Deal size: 44,736,842 shares (100% primary) plus 15% greenshoe (100% primar=)
Offer range: $18.00 - $20.00
Exchange: Nasdaq
2
EFTA_R1_01760462
EFTA02582669
Anticipated pricing: Wednesday, April 16th (Post Market Close)
Business description:
Sabre is a leading technology solutions provider to the global travel and tourism industry. They span the breadth of a
highly complex, $6.6 trillion global travel ecosystem, providing key software and services to a broad range of travel
suppliers and travel buyers. Through Sabre's Travel N=twork business, we process hundreds of millions of transactions
annually, connect=ng the world's leading travel suppliers, including airlines, hotels, car rental brands, rail carriers, cruise
lines and tour operators, with travel buyers in a comprehensive travel marketplace.
Roadshow:
Fri 04/04 - New York (Launch)
Mon 4/07 - London
Tues 4/08 - Baltimore / Chicago
Wed 04/09 - New York
Thur 4/10 - New York
Fri 4/11 - Boston
Mon 4/14 - San Fran
Tues 4/15 - Denver / Midwest
Wed 4/16 - TBD (Pricing)
Bookrunners:
Morgan Stanley
Goldman Sachs
BAML
Deutsche Bank
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this
communication relates. Before you invest, you should read the prospectus in that registration statement and other
documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may
get these documents for free by visiting EDGAR on the SEC Web site, at <=>www.sec.gov <http://=ww.sec.gov/> .
Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the
prospectus if you request it by calling toll-free 1-800-503-4611 <tel:1-800-503-4611> or by mail from Deutsche Bank
Securities Inc., 60 Wall Street, New York, New York 10016, or by email at [email protected]
<mailto:[email protected]=m>
3
EFTA_R1_01760463
EFTA02582670
Tazia Smith
Director I Key Client Partners - US
DB Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 10154-0004 New York, NY, USA Tel. ORInnillailla
Fax
This communication may contain confidential and/or privileged information.<=r> If you are not the intended recipient
(or have received this communicationar> in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the material in this communication is strictly
forbidden.
Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be
regarded as such.
The information contained in this communication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized
use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you
have received this communication in error, please notify us immediately by return e-mail or by e-mail to
[email protected]</=ont> <mailto:[email protected]=target=_blank> , and destroy this communication and
all copies thereof, including all attachments. copyright -all rights reserved
This communication may contain confidential and/or privileged information.ar> If you are not the intended recipient
(or have received this communication<=r> in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the material in this communication is strictly
forbidden.
Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be
regarded as such.
The information contained in this communication is confidential, may be attorney-client privileged, may constitute
inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized
4
EFTA_R1_01760464
EFTA02582671
use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you
have received this communication in error, please notify us immediately by return e-mail or by e-mail to
[email protected]</=ont> <mailto:[email protected]=target=_blank> , and destroy this communication and
all copies thereof, including all attachments. copyright -all rights reserved
This communication may contain confid=ntial and/or privileged information.
If you are not the intended recipient (or have received this communication<=r> in error) please notify the sender
immediately and destroy this communication. Any unauthorized copying, disclosure or distribution of the<=r> material
in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information contained in this communication should not be
regarded as such.
5
EFTA_R1_01760465
EFTA02582672
Technical Artifacts (10)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.sec.govEmail
[email protected]Email
[email protected]Phone
1-800-503-4611Phone
2582668Phone
2582669Phone
2582670Phone
2582671Phone
2582672URL
http://=ww.sec.govRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.